Menu

Viruses on the Brain

Viral infections of the central nervous system may trigger cytokines that induce seizures.

May 1, 2013
Beth Marie Mole

EDITOR'S CHOICE IN IMMUNOLOGY

DISSECTING SEIZURES: Mice that suffer seizures after viral infection have a greater number of macrophages (green) in the brain.COURTESY OF ROBERT FUJINAMThe paper
M.F. Cusick et al., “Infiltrating macrophages are key to the development of seizures following virus infection,” J Virol, 87:1849-60, 2013.

The matter
Of the approximately 2.2 million Americans affected by epilepsy, a third do not respond to current antiseizure treatments, and nearly three quarters of all cases have unknown causes. Though scientists have previously linked more than 100 species of viruses that infect the central nervous system (CNS) to patients suffering from recurring seizures, the significance of viral infections in epilepsy is still unclear.

The model
Researchers at the University of Utah School of Medicine, led by Robert Fujinami, had previously developed a mouse model that suffered from seizures after infection with a CNS-targeting virus. Though the mice could clear the infection, they often continued to have seizures. To dissect how the virus might spark recurring seizures during and long after infection, Fujinami and his team took a close look at the immune responses.

The match
Fujinami’s team found that during a viral brain infection, infiltrating macrophages produce high levels of a cytokine called interleukin 6 (IL-6), which, among other cytokines, had previously been linked to seizures in the mice. To understand the importance of these IL-6–spewing macrophages, the team used a drug to block them from the CNS, which resulted in the mice having fewer seizures. Though it’s still unclear how the virus triggers seizures after the infection, Fujinami and his team suspect that macrophages continue to swarm the CNS.

The aftermath
The results suggest that “the side effect of this powerful immune response is a disruption in brain function and the ensuing brain seizures,” says Thomas M. Petro of the University of Nebraska Medical Center, who was not involved in the study.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.